Monitor for any subsequent prospectus supplement or insider Form 144 filings indicating Patel Family selling. The S-3 itself is a resale-only shelf, so no new dilution, but the overhang and weak liquidity (cash < $1M, deficit > $145M) suggest continued reliance on dilutive financing or related-party loans. Watch for ATM activity and any restructuring announcements.
Price Chart
Executive Summary
Tevogen Bio filed an S-3 shelf registration to register up to 375,000 shares of common stock for resale by The Patel Family, LLP, a related party and insider holding ~$3.0M in pre-funded warrants issued in a May 2026 PIPE. The company receives no proceeds from this resale (only a nominal $37.50 aggregate warrant exercise price). Combined with the March 31, 2026 10-Q showing only $692k cash, a $9.8M stockholders' deficit, and a $5.4M quarterly net loss, this registration signals insider selling intent while the company remains in a precarious capital position.
Key Financial Metrics
Key Facts
- Up to 375,000 shares registered for resale (8.9% of 4,219,343 shares outstanding as of June 11, 2026).
- Maximum aggregate offering price of $3,849,375 based on $10.265 per share (June 5, 2026 pricing).
- Selling stockholder is The Patel Family, LLP, a related party (controlled by Dr. Manmohan Patel, who is also the company's primary lender).
- Company had only $692k cash, $1.65M in notes payable, $6.4M in loan agreement debt, and a $9.8M stockholders' deficit as of March 31, 2026.
- Q1 2026 net loss of $5.4M; accumulated deficit of $145.1M; operating cash burn of $2.7M in the quarter.
- The company has an active ATM sales agreement (raised $989k net in Q1 2026) and has already been relying on related-party financing.
Financial Impact
Resale of up to 375k shares (~$3.8M at registration pricing) could increase daily trading supply and pressure the stock. The company's cash runway appears extremely limited given $692k cash against $2.7M quarterly burn, with no revenue.
Risk Factors
- Insider/related-party selling pressure could further depress the stock price.
- Company's cash position ($692k) is insufficient to fund operations beyond Q2 2026; likely need for additional dilutive financing.
- Negative stockholders' equity ($9.8M) and no revenue raise going-concern risk.
- Dilution from the existing ATM program and potential future offerings.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3 Filing (Primary) | 0001493152-26-028495 |
| Exhibit: ex107.htm | 0001493152-26-028495 |
| Exhibit: ex5-1.htm | 0001493152-26-028495 |
| Exhibit: ex23-1.htm | 0001493152-26-028495 |
| Document: 0001493152-26-028495-index-headers.html | 0001493152-26-028495 |
| Document: 0001493152-26-028495-index.html | 0001493152-26-028495 |
| Document: 0001493152-26-028495.txt | 0001493152-26-028495 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 30, 2026 27d ago | 8-K | $6.72 | awaiting T+60 | — | $6.28 (−6.55%) |
Sep 16, 2026 5w ago | SC 13D/A | $7.71 | awaiting T+60 | — | $6.28 (−18.55%) |
Sep 16, 2026 5w ago | SC 13D/A | $7.71 | awaiting T+60 | — | $6.28 (−18.55%) |
Sep 16, 2026 5w ago | 8-K | $7.71 | awaiting T+60 | — | $6.28 (−18.55%) |
Jun 26, 2026 17w ago | EFFECT | $7.00 $7.43 | ▼ −6.14% | ▼ −1.66% | $6.28 (+10.29%) |
Jun 12, 2026 19w ago | S-3 | $10.02 $7.34 | ▲ +26.75% | ▲ +27.75% | $6.28 (+37.33%) |
Jun 9, 2026 20w ago | Press Release | $10.75 $7.17 | ▼ −33.30% | ▼ −37.12% | $6.28 (−41.58%) |
May 28, 2026 21w ago | Press Release | $8.04 $6.75 | ▼ −16.04% | ▼ −17.78% | $6.28 (−21.89%) |
May 21, 2026 22w ago | Press Release | $11.57 $6.58 | ▼ −43.10% | ▼ −47.40% | $6.28 (−45.70%) |
Mar 25, 2026 30w ago | Press Release | $5.18 $9.79 | ▲ +88.90% | ▲ +75.44% | $6.28 (+21.24%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers